Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Saedisomeolia, Ahmad ^a   Taheri, Ehsaneh ^b   Djalali, Mahmoud ^a   Moghadam, Ali M ^c   Qorbani, Mostafa ^d,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Lipid profile; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IRAN; LIPID ANALYSIS; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84908141902     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-13-7     Document Type: Article

References (34)

1. Mitsuhashi T. Functional domain structure of thyroid hormone receptor and interaction among T3, T3 receptor and T3RE. Nihon Rinsho 1994, 52(4):910.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053. 10.2337/diacare.27.5.1047, 15111519.
3. Frohlich J, Dobiasova M, Lear S, Lee KWJ. The role of risk factors in the development of atherosclerosis. Crit Rev Cl Lab Sci 2001, 38(5):401-440.
4. Sadie H, Styger G, Hapgood J. Expression of the mouse gonadotropin-releasing hormone receptor gene in alpha T3-1 gonadotrope cells is stimulated by cyclic 3',5'-adenosine monophosphate and protein kinase A, and is modulated by Steroidogenic factor-1 and Nur77. Endocrinology 2003, 144(5):1958-1971. 10.1210/en.2002-220874, 12697703.
5. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80(6):1706S-1709S.
6. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007, 20(7):713-719. 10.1016/j.amjhyper.2007.01.017, 17586404.
7. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr 2008, 11(1):7-12.
8. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511. 10.1161/CIRCULATIONAHA.107.706127, 2726624, 18180395.
9. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373. 10.4065/81.3.353, 16529140.
10. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrin Diab Obes 2002, 9(1):87-98.
11. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes care 2007, 30(10):2569-2570. 10.2337/dc07-0292, 17626891.
12. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, Hu FB. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29(3):650-656. 10.2337/diacare.29.03.06.dc05-1961, 16505521.
13. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27(12):2813-2818. 10.2337/diacare.27.12.2813, 15562190.
14. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003, 17(3):509-511.
15. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 2004, 79(5):820-825.
16. Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD, Bleske BE. Vitamin D and cardiovascular disease. J Hum Pharmacol Drug Ther 2009, 29(6):691-708.
17. Hollis B, MacFarlane G, Valcour A. Clinical significance and assessment of 25 OH vitamin D. Advance/Laboratory 2005, 72-78.
18. John WG. Haemoglobin A1c: analysis and standardisation. Clin Chem Lab Med 2003, 41(9):1199-1212.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
20. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocr Metab 2011, 96(1):53-58. 10.1210/jc.2010-2704, 3046611, 21118827.
21. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 2005, 28(5):1228-1230. 10.2337/diacare.28.5.1228, 15855599.
22. Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Simvastatin does not affect vitamin D status, but low vitamin D levels are associated with dyslipidemia: results from a randomised, controlled trial. Inte J Endocr 2009, Volume 2010 (2010), Article ID 957174, 6 pages http://dx.doi.org/10.1155/2010/957174.
23. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011, 50(4):303-312. 10.1016/j.plipres.2011.05.001, 21640757.
24. Querfeld U, Hoffmann MM, KLAUS G, Eifinger F, Ackerschott M, Michalk D, Kern PA. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J Am Soc Nephrol 1999, 10(10):2158-2164.
25. Wang JH, Keisala T, Solakivi T, Minasyan A, Kalueff AV, Tuohimaa P. Serum cholesterol and expression of ApoAI, LXR [beta] and SREBP2 in vitamin D receptor knock-out mice. The J Steroid Biochem 2009, 113(3-5):222-226.
26. Christensen R, Lorenzen JK, Svith CR, Bartels E, Melanson E, Saris W, Tremblay A, Astrup A. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a metaâ€analysis of randomized controlled trials. Obes Rev 2009, 10(4):475-486. 10.1111/j.1467-789X.2009.00599.x, 19493303.
27. Vaskonen T, Mervaala E, Sumuvuori V, Sepp{currency sign}nen-Laakso T, Karppanen H. Effects of calcium and plant sterols on serum lipids in obese Zucker rats on a low-fat diet. Brit J Nutr 2002, 87(03):239-245.
28. Reid IR, Mason B, Horne A, Ames R, Clearwater J, Bava U, Orr-Walker B, Wu F, Evans MC, Gamble GD. Effects of calcium supplementation on serum lipid concentrations in normal older women: A randomized controlled trial. Am J Med 2002, 112(5):343-347. 10.1016/S0002-9343(01)01138-X, 11904107.
29. Ni Z, Smogorzewski M, Massary SG. Effect of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrin 1994, 135:1837-1844.
30. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary cacium. FASEB J 2000, 14:1132-1138.
31. John WG, Noonan K, Mannan N, Boucher BJ. Hypovitaminosis D is associated with reductions in serum apolipoprotein AI but not with fasting lipids in British Bangladeshis. Am J Clinl Nutr 2005, 82(3):517.
32. Deluca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80:1689-1696.
33. Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it?. J Am Acad Dermatol 2006, 54(2):301-317. 10.1016/j.jaad.2005.11.1057, 16443061.
34. Lips P. World wide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010, 121:297-300. 10.1016/j.jsbmb.2010.02.021, 20197091.